At Viatris, we are committed to making medicines more accessible by increasing competition and finding policy solutions that ensure benefits of competition reach patients. We recognize that the price of medicines can present an access challenge for patients, particularly when health system policies do not adequately support the equitable provision of health services. We believe that the value created by universal access to appropriate, high-quality medicines, particularly in the off-patent sector, is greater than the savings achieved by cuts to health and medicines budgets.